Actively Recruiting

Early Phase 1
Age: 18Years +
MALE
NCT05802121

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Led by Western University · Updated on 2025-08-20

30

Participants Needed

1

Research Sites

99 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The overriding objectives of this study are: 1. Primary outcomes: 1. To confirm that administration of oral acetate increases the proportion of A. muciniphilia in the stool samples of patients with metastatic, castration-sensitive prostate cancer compared to a standard of care arm. 2. To confirm tolerability and assess for side effects of oral acetate supplementation. 2. Secondary outcomes: 1. To determine if increased counts of A. muciniphilia correlate with improved metabolic parameters and improved bone health.

CONDITIONS

Official Title

Akkermansia Muciniphilia and Metabolic Side Effects of ADT

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Men 18 years of age or older with confirmed metastatic castration-sensitive prostate adenocarcinoma planned to receive ADT
  • Must have baseline imaging with CT of the abdomen and pelvis plus bone scan, or PSMA PET scan
Not Eligible

You will not qualify if you...

  • Age less than 18 years
  • Primary neuroendocrine prostate cancer
  • Treatment with ADT within the year before enrollment
  • Planned or current use of chromium supplementation during the study
  • Planned or current use of apple cider vinegar supplementation during the study
  • Unable to provide informed consent or understand/read English without an interpreter
  • Liver function greater than twice the upper limit of normal
  • Any medical or lifestyle condition posing significant risk or affecting ability to complete the study
  • Use of antibiotics that cannot be stopped for a washout period and during the trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

London Health Sciences Centre - Victoria Hospital

London, Ontario, Canada, N6A5W9

Actively Recruiting

Loading map...

Research Team

K

Kaydee Connors

CONTACT

S

Stephen Mardell

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Akkermansia Muciniphilia and Metabolic Side Effects of ADT | DecenTrialz